Professor Mark Daniell Joined to OBM Scientific Board
14th July 2025
Our Partner ACRO Biomedical Co., Ltd. Receives Approval for Its Biocompatible Cornea from Taiwan FDA, the Department of Health and Welfare 14th March 2025
March 14, 2025OBM Attends BioAsia-Taiwan Conference and ACRO Biomedical Announces to Outlicense the Market Rights in 10 ASEAN Countries of its Biocompatible Artificial Cornea, ABCcolla Collagen Ophthalmic Matrix, to Vietnam’s CT Group 23th ~ 27 July 2025
July 27, 2025We highly welcome Professor Mark Daniell to join the OBM Scientific Board. He brings significant experience of medical research and clinical surgery to the company.
Professor Mark Daniell is an ophthalmic surgeon and is working to develop a tissue-engineered cornea. He leads the corneal research team at the Centre Eye Research Australia (CERA) as the Head of Corneal Research. He is also a senior consultant at Royal Victorian Eye and Ear Hospital, serving as Head of the Corneal Service since 2011, and overseeing a team of surgeons performing corneal transplantation for Victoria.
Professor Mark Daniell is the Founding Chair of the ANZ Corneal Society and Medical Director of the Lions Eye Bank. He is the former President of RANZCO (2017-2018), the Royal Australian and New Zealand College of Ophthalmologists, and served on the RANZCO board for 12 years, with roles including Vice President and Treasurer. He was Chair of the Ophthalmic Research Institute of Australia from 2005 to 2011. He is President of the World Ophthalmology Congress in 2022.
Professor Mark Daniell has participated various research projects, including development of a tissue-engineered cornea, investigation of the cellular basis of corneal graft rejection and a principal investigator of an international phase 3 clinical trial on a drug candidate in patients with pterygium, a non-cancerous, fleshy growth of tissue on the eye’s surface that starts at the clear part of the white of the eye (conjunctiva) and can grow onto the cornea.
